Richard Partl

Radiomics for risk stratification in brain metastases: potential in melanoma brain metastases

The identification of quantitative non-invasive imaging biomarkers, including radiomics, may complement molecular characterization and thereby improve clinical management of neuro-oncological patients. We aimed to identify imaging predictors with improved performance over clinica...